DHCR7-DT and early-onset autosomal dominant Alzheimer disease: These findings suggest that the BC can be used as natural pharmaceutical material for the treatment of cholinergic neurotoxicity-associated neurovascular disorders such as vascular dementia and Alzheimer’s disease due to its AChE and AP enzyme inhibitory actions.